Inventor · disambiguated record
Reinhard Nubbemeyer
Also filed as: NUBBEMEYER REINHARD
9 granted patents·21 pending applications·35 citations·filing 2002–2022
84Inventor score
Files withBayer Pharma AG18BAYER IP GMBH3BAYER AG2BAYER SCHERING PHARMA AG2BAYER ANIMAL HEALTH GMBH1
Top patents by PatentIndex Score
30 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0292US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0390US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0490US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0585US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 0670US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 0769US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 0867US12459916B2Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBayer Pharma AG·Filed 2022·Granted Nov 4, 2025·0 cites·22 claims
- 0967US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1063US7361645B2Androgenic 7-substituted 11-halogen steroidsBAYER SCHERING PHARMA AG·Filed 2002·Granted Apr 22, 2008·2 cites·20 claims
- 1157US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1254US7262023B2Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereofBAYER SCHERING PHARMA AG·Filed 2003·Granted Aug 28, 2007·0 cites·10 claims
- 1353US2024239804A1Furoindazole derivatives as antagonists or inhibitors of gpr84BAYER AG·Filed 2022·Application pending·0 cites
- 1452US2007298456A1Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereofZORN LUDWIG·Filed 2007·Application pending·0 cites
- 1551US2023257351A1Substituted n-phenylacetamides having p2x4 receptor antagonistic activityBAYER AG·Filed 2021·Application pending·0 cites
- 1646US2020216413A1Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBAYER ANIMAL HEALTH GMBH·Filed 2017·Application pending·0 cites
- 1745US2007135375A1Sulfamoyl sulfonate prodrugsWYRWA RALF·Filed 2006·Application pending·0 cites
- 1842US2020085791A1[(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1942US2006100180A1Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said compositionNUBBEMEYER REINHARD·Filed 2003·Application pending·0 cites
- 2040US2015080438A16,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2140US2014357655A1Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonistsBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2239US2016052936A1Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonistsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2337US10167293B2[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Granted Jan 1, 2019·0 cites·18 claims
- 2437US2020079758A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2536US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 2636US2015065472A1Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapyBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2736US2015119372A1Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2835US2020087284A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1, 2, 3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2935US2014288035A118-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosisBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 3033US2018338980A1Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Reinhard Nubbemeyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →